-
EHDN 2026 Part 1: What’s next in the Huntington’s disease treatment pipeline?
9 min read
Latest News
-
Skyhawk’s drug trial takes flight in the US
4 min read
Skyhawk’s FALCON-HD trial has dosed the first participants in the US with the drug, SKY-0515. The once-daily pill targets two drivers of HD, but does it actually slow disease? That’s the big question this study hopes to answer.
-
EuroBuzz 2014 Video, day one
13 min read
Video of our first live session at the European Huntington's Disease Network Meeting.
-
EuroBuzz 2014 Video, day two
21 min read
Video of our second live session at the European Huntington's Disease Network Meeting.
-
Melatonin alterations in Huntington's disease help explain trouble with sleep
7 min read
Study shows HD patients have decreased levels of melatonin, which may explain why so many suffer from sleep problems
-
EuroBuzz 2014: day three
4 min read
Our third and final report on the 2014 European Huntington's Disease Network meeting in Barcelona
-
EuroBuzz 2014: day two
7 min read
HDBuzz reports on the second day of science at the European HD Network meeting in Barcelona
-
EuroBuzz 2014: day one
11 min read
Highlights from the opening day of the 2014 European Huntington's Disease network in Barcelona, Spain
-
Going toe-to-toe with tau: new insights into the chemical basis of Huntington’s disease
6 min read
Does tau protein – which causes problems in other neurodegenerative diseases – contribute to Huntington's disease?
-
New results bring BDNF therapies into focus
7 min read
Some unexpected findings suggest new ways to aim at an old target in HD
-
2CARE study of coenzyme Q for Huntington's disease ends in disappointment
7 min read
The largest ever HD drug trial, testing coenzyme Q10, is halted for 'futility'. What does that mean for HD research?
-
A starring role for astrocytes in Huntington's disease?
6 min read
Brain cells called astrocytes might play a bigger role than previously thought in Huntington's disease
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
